Skip to main content
SpringerLink
Log in

Funzione endocrina e decadimento cognitivo

  • RASSEGNA
  • Published:
L'Endocrinologo Aims and scope

Sommario

La demenza è una patologia strettamente correlata all’invecchiamento che interessa circa 50 milioni di persone nel mondo, con un notevole impatto socio-economico; la malattia di Alzheimer rappresenta più del 50% dei casi. Sebbene non esistano attualmente terapie in grado di modificare significativamente la progressione di malattia, la necessità di una diagnosi precoce ha portato a un crescente interesse per i fattori di rischio modificabili, ponendo l’accento sulla complessa interazione tra sistema endocrino e funzioni cognitive.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Bibliografia

  1. Bavarsad K, Hosseini M, Hadjzadeh M-A-L, Sahebkar A (2019) The effects of thyroid hormones on memory impairment and Alzheimer’s disease. J Cell Physiol. https://doi.org/10.1002/jcp.28198

    Article  PubMed  Google Scholar 

  2. Calsolaro V, Bottari M, Coppini G et al. (2021) Endocrine dysfunction and cognitive impairment. Minerva Endocrinol. https://doi.org/10.23736/S0391-1977.20.03295-2

    Article  Google Scholar 

  3. George KM, Lutsey PL, Selvin E et al. (2019) Association between thyroid dysfunction and incident dementia in the atherosclerosis risk in communities neurocognitive study. J Endocrinol Metab 9(4):82–89

    Article  Google Scholar 

  4. Aubert CE, da Costa A, Feller M (2017) The association between subclinical thyroid dysfunction and dementia: the health. Aging Body Compos (Health ABC) Study 85(5):617–629

    Google Scholar 

  5. Kalmijn S, Mehta KM, Pols HA et al. (2000) Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol 53(6):733–737

    Article  CAS  Google Scholar 

  6. Pasqualetti G, Pagano G, Rengo G et al. (2015) Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis. J Clin Endocrinol Metab 100(11):4240–4248

    Article  CAS  Google Scholar 

  7. Mori T, Inoue D, Kosugi S et al. (1988) Effects of low dose L-triiodothyronine administration on mental, behavioural and thyroid states in elderly subjects. Endocrinol Jpn 35(4):585–592

    Article  CAS  Google Scholar 

  8. Lukaszyk E, Bien-Barkowska K, Bien B (2018) Cognitive functioning of geriatric patients: is hypovitaminosis D the next marker of cognitive dysfunction and dementia? Nutrients 10(8):1104

    Article  Google Scholar 

  9. Stein MS, Scherer SC, Ladd KS, Harrison LC (2011) A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer’s disease. J Alzheimers Dis 26(3):477–484

    Article  CAS  Google Scholar 

  10. Annweiler C, Herrmann FR, Fantino B et al. (2012) Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: a pre-post pilot study. Cogn Behav Neurol 25(3):121–127

    Article  Google Scholar 

  11. Ott A, Stolk RP, van Harskamp F et al. (1999) Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 53(9):1937–1942

    Article  CAS  Google Scholar 

  12. Ohara T, Doi Y, Ninomiya T et al. (2011) Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology 77(12):1126–1134

    Article  CAS  Google Scholar 

  13. Li W, Risacher SL, Huang E et al. (2016) Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort. Neurology 87(6):595–600

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Ninomiya T (2014) Diabetes mellitus and dementia. Curr Diab Rep 14(5):487

    Article  Google Scholar 

  15. Calsolaro V, Edison P (2015) Novel GLP-1 (Glucagon-Like Peptide-1) analogues and insulin in the treatment for Alzheimer’s disease and other neurodegenerative diseases. CNS Drugs 29(12):1023–1039

    Article  CAS  Google Scholar 

  16. Zhao WQ, Townsend M (2009) Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer’s disease. Biochim Biophys Acta 1792(5):482–496

    Article  CAS  Google Scholar 

  17. Neumann KF, Rojo L, Navarrete LP et al. (2008) Insulin resistance and Alzheimer’s disease: molecular links & clinical implications. Curr Alzheimer Res 5(5):438–447

    Article  CAS  Google Scholar 

  18. Rahman A, Jackson H, Hristov H et al. (2019) Sex and gender driven modifiers of Alzheimer’s: the role for estrogenic control across age, race, medical, and lifestyle risks. Front Aging Neurosci 11:315

    Article  CAS  Google Scholar 

  19. Mosconi L et al. (2018) Increased Alzheimer’s risk during the menopause transition: a 3-year longitudinal brain imaging study. PLoS ONE 13(12):e0207885

    Article  CAS  Google Scholar 

  20. Lisco G, Giagulli VA, De Tullio A et al. (2020) Age-related male hypogonadism and cognitive impairment in the elderly: focus on the effects of testosterone replacement therapy on cognition. Geriatrics 5(4):76

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unità di Geriatria, Azienda Ospedaliera Universitaria Pisana, Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa, Pisa, Italia

    Valeria Calsolaro, Alessia Maria Calabrese, Sara Rogani, Filippo Niccolai, Nadia Caraccio & Fabio Monzani

Authors
  1. Valeria Calsolaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessia Maria Calabrese
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sara Rogani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Filippo Niccolai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nadia Caraccio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fabio Monzani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabio Monzani.

Ethics declarations

Conflitto di interesse

Gli autori Valeria Calsolaro, Alessia Maria Calabrese, Sara Rogani, Filippo Niccolai, Nadia Caraccio e Fabio Monzani dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo studio non hanno eseguito studi sugli animali.

Additional information

Proposto da Giovanni Vitale.

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Informazioni Supplementari

I link al materiale elettronico supplementare sono elencati qui sotto.

(DOC 30 kB)

(DOC 29 kB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Calsolaro, V., Calabrese, A.M., Rogani, S. et al. Funzione endocrina e decadimento cognitivo. L'Endocrinologo 22, 503–508 (2021). https://doi.org/10.1007/s40619-021-00975-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-021-00975-5

Parole chiave

Search

Navigation